One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
Join Ipsos’ upcoming webinar, "GenAI-Powered Persona Bots: Bringing Healthcare Segmentations to Life," in which our experts will demonstrate how GenAI-enabled persona bots can transform the utility and value of healthcare segmentations. Ipsos will also be joined by one of our client partners who will share their own experiences and perspectives.
Younger people (particularly young women) are the most likely to feel depressed and take time off work due to stress according to an Ipsos report for World Mental Health Day 2024
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.
Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges
Conducted monthly in 29 countries among a panel of over 20,000 adults for more than a decade, What Worries the World survey offers an exceptional snapshot of world opinion on pressing global issues.
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
![[Webinar] Gen-AI-Powered Persona Bots](/sites/default/files/styles/list_item_image/public/ct/event/2024-10/Bringing%20healthcare%20segmantations%20to%20life_0.png?itok=T1uONrhE)
